 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Development of Clinical Data Mart of HMG-CoA Reductase Inhibitor for Varied Clinical Research |
| Hun-Sung Kim, Hyunah Kim, Yoo Jin Jeong, Tong Min Kim, So Jung Yang, Sun Jung Baik, Seung-Hwan Lee, Jae Hyoung Cho, In Young Choi, Kun-Ho Yoon |
|
Endocrinol Metab. 2017;32(1):90-98. Published online February 28, 2017 DOI: https://doi.org/10.3803/EnM.2017.32.1.90 |
|
Development of Clinical Data Mart of HMG-CoA Reductase Inhibitor for Varied Clinical Research Endocrinology and Metabolism. 2017;32(1):90  Newer HMG-CoA reductase inhibitor (statin) therapies Clinical Cardiology. 2001;24(S2):10-13 P-7-29 Long term effect of the HMG CoA reductase inhibitor (CS-514) on lipid and glucose metabolism of hyperlipidemic diabetics Diabetes Research and Clinical Practice. 1987;3:S76 HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data Atherosclerosis. 1998;138(1):11-24 The pharmacology of fluvastatin, a new HMG-CoA reductase inhibitor Clinical Cardiology. 2009;17(S4):IV-3-IV-10 Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase European Journal of Clinical Pharmacology. 1991;40(1):S15-S18 Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase European Journal of Clinical Pharmacology. 1991;40(S1):S15-S18 Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy Clinical Endocrinology. 2007;68(2):326-326 HMG CoA reductase-inhibitor-related myopathy and the influence of drug interactions Internal Medicine Journal. 2002;32(9-10):486-490 C4. Cost-effectiveness trends of HMG-CoA reductase inhibitor therapy in a managed-care population Clinical Therapeutics. 1996;18:20-21 |
